Surya Medika Perkasa is primarily engaged in pharmaceuticals activity. Its headquarters is located in Jawa Timur. The company was founded in 1994. Surya Medika Perkasa was established by a group of visionary entrepreneurs with a mission to enhance healthcare accessibility and quality in Indonesia. The company focuses on the production and distribution of a wide range of pharmaceutical products, including prescription medications, over-the-counter drugs, and health supplements. As a key player in the Indonesian pharmaceutical industry, Surya Medika Perkasa operates several branches across the country, ensuring a robust local geographical footprint. The company is committed to expanding its reach and currently exports its products to several Southeast Asian markets, contributing to its growing international presence. Surya Medika Perkasa is known for its flagship brands, which include well-regarded names in the healthcare sector. The company has established strategic partnerships with leading global pharmaceutical firms to enhance its product offerings and leverage advanced technologies in drug manufacturing. In addition to its core pharmaceutical business, Surya Medika Perkasa is actively involved in community health initiatives and collaborates with various healthcare organizations to promote public health awareness. The company is a member of several industry associations, reflecting its commitment to maintaining high standards in pharmaceutical manufacturing and distribution. With a vision to become a leading pharmaceutical company in the region, Surya Medika Perkasa is dedicated to innovation, quality, and customer satisfaction. The company's mission is to improve the health and well-being of communities by providing safe, effective, and affordable healthcare solutions.
Headquarters
RT 004 RW 003
Surabaya; East Java;
Postal Code: 60221
Contact Details: Purchase the PT Surya Medika Perkasa report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service